Redpoint Investment Management Pty LTD Jazz Pharmaceuticals PLC Transaction History

Redpoint Investment Management Pty LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$128.64 - $184.79 $272,202 - $391,015	-2,116 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$160.2 - $186.42 $33,001 - $38,402	-206 Reduced 8.87%	2,116 $376,000
Q3 2020 Oct 09, 2020	SELL	$105.46 - $144.13 $489,545 - $669,051	-4,642 Reduced 66.66%	2,322 $331,000
Q2 2020 Jul 17, 2020	SELL	$95.68 - $121.88 $56,355 - $71,787	-589 Reduced 7.8%	6,964 $768,000
Q1 2020 Apr 22, 2020	SELL	$87.74 - $152.74 $30,972 - $53,917	-353 Reduced 4.46%	7,553 $753,000
Q1 2018 Aug 09, 2018	BUY	$135.59 - $157.16 $149,962 - $173,818	1,106 Added 16.26%	7,906 $1.19 Million
Q4 2017 Aug 09, 2018	BUY	$131.06 - $150.39 $891,208 - $1.02 Million	6,800	6,800 $915,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.